UNICREDIT BANK/CALL/ELI LILLY & CO/1100/0.1/14.01.26 Stock

Warrant

DE000HD2FCM3

Market Closed - BOERSE MUENCHEN 03:45:07 2024-05-24 pm EDT
6.33 EUR -1.09% Intraday chart for UNICREDIT BANK/CALL/ELI LILLY & CO/1100/0.1/14.01.26
Current month+12.63%
1 month+42.25%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-24 6.33 -1.09%
24-05-23 6.4 +6.14%
24-05-22 6.03 +0.67%
24-05-21 5.99 +14.53%
24-05-20 5.23 +3.77%

Real-time BOERSE MUENCHEN

Last update May 24, 2024 at 03:45 pm EDT

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ELI LILLY AND COMPANY
IssuerLogo Issuer UniCredit UniCredit
WKN HD2FCM
ISINDE000HD2FCM3
Date issued 2024-02-05
Strike 1,100 $
Maturity 2026-01-14 (599 Days)
Parity 10 : 1
Emission price 3.38
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 6.4
Lowest since issue 3.25
Delta0.36x
Omega 4.316
Premium44.54x
Gearing11.94x
Moneyness 0.7344
Difference Strike 292.6 $
Difference Strike %+26.60%
Spread 0.13
Spread %2.06%
Theoretical value 6.235
Implied Volatility 32.76 %
Total Loss Probability 77.81 %
Intrinsic value 0.000000
Present value 6.235
Break even 1,167.64 €
Theta-0.09x
Vega0.36x
Rho0.34x

Company Profile

Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows: - endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems; - oncology (19.5%); - immunology diseases (11.1%); - neurology (8.4%): primarily drugs used in treating depression and schizophrenia; - other (3.3%). Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
More about the company

Ratings for Eli Lilly and Company

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Eli Lilly and Company

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
807.4 USD
Average target price
850.8 USD
Spread / Average Target
+5.37%
Consensus